Information Technology
Weebit Nano Ltd (WBT)
Weebit Nano develops advanced memory technology for next-generation semiconductor devices.
Market Cap
A$1.1B
Shares on Issue
0.35B
Price Chart
AI Analysis
Weebit Nano is commercialising Resistive RAM (ReRAM) technology, targeting embedded memory markets. Progress on customer qualification and licensing deals will be pivotal.
While the addressable market is large, the company remains pre-revenue, making funding and milestone delivery key investor considerations.
Bull Case
- • ReRAM adoption could unlock licensing revenue.
- • Strategic semiconductor partners can validate technology.
- • Growing AI workloads demand new memory solutions.
Bear Case
- • Commercialisation timelines may slip.
- • Competition from incumbent memory technologies.
- • Funding risk for ongoing R&D.
Recent Announcements
Notification of cessation of securities - WBT
Application for quotation of securities - WBT
Half Year Results Announcement
🚨 Price SensitiveHalf Year Results Announcement
Appendix 4D and FY26 Interim Financial Statements
🚨 Price SensitiveAppendix 4D and FY26 Interim Financial Statements
Ceasing to be a substantial holder
FAQs
What is Weebit Nano's tech?
Weebit Nano develops ReRAM memory for embedded chips.
Is WBT profitable?
Weebit Nano is pre-revenue and focused on R&D.
What drives WBT shares?
Licensing deals, partner announcements, and tech milestones.
Key Metrics
Related Stocks
Information Technology
BRNBrainchip Holdings Ltd
A$0.13
-51.9% 1Y
Brainchip develops neuromorphic AI processors designed for ultra-low power edge computing.
Information Technology
APXAppen Ltd
A$1.48
85.0% 1Y
Appen provides data annotation and AI training services to major technology companies.
Information Technology
1TTThrive Tribe Technologies Limited
A$0.00
-97.5% 1Y
Thrive Tribe Technologies is an Australian technology company focused on the health and wellness sector. The company is developing its core product, the 'Thrive Tribe' platform, a digital application designed to connect individuals and build communities around shared health goals and interests. As a micro-cap entity, 1TT is in a very early, pre-commercialisation stage, having recently pivoted its strategy and changed its name from Ookami Limited.